Equity Capital Markets

Company · CIK 2056611

Latigo Biotherapeutics, Inc.

CIK2056611 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
ListedLTGO (Nasdaq)
First annual or quarterly report2026-09-03

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-297518
IPOFinal prospectus
 2026-07-172026-08-075

Filings

6
FiledFilingRegistrationAccession
2026-08-07424B4Final prospectus 333-2975180001193125-26-340329
2026-08-06EFFECTDeclared effective 333-2975189999999995-26-002566
2026-08-04S-1/AAmendment 333-2975180001193125-26-331205
2026-08-03S-1/AAmendment 333-2975180001193125-26-329431
2026-07-17S-1Registration filed 333-2975180001193125-26-307306
2026-03-27DRSDraft made public 377-091840001193125-26-129261

All filings of this company · CSV